翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03692 翰森制药

未开盘 12-23 16:08:09

37.680

-0.720

-1.87%

最高38.720	最低37.520	成交量495.14万
今开38.380	昨收38.400	日振幅3.13%
总市值2,282亿	流通市值2,282亿	总股本60.55亿
成交额1.88亿	换手率0.08%	流通股本60.55亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"翰森制药","latestPrice":37.68,"timestamp":1766477289009,"preClose":38.4,"halted":0,"volume":4951381,"delay":0,"floatShares":6055000000,"shares":6055000000,"eps":0.8168249186427234,"marketStatus":"未开盘","change":-0.72,"latestTime":"12-23 16:08:09","open":38.38,"high":38.72,"low":37.52,"amount":187574545,"amplitude":0.03125,"askPrice":37.68,"askSize":30000,"bidPrice":37.62,"bidSize":24000,"shortable":3,"etf":0,"ttmEps":0.8896994854294181,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766539800000},"marketStatusCode":0,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":38.4,"dividendRate":0.009877,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":0.7941513194851338,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692/wiki","defaultTab":"wiki","newsList":[{"id":"2593451238","title":"每日卖空追踪 | 翰森制药 12月22日卖空量成交38.2万股，卖空比例为7.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593451238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593451238?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392235,"startTime":"0","endTime":"0","summary":"翰森制药北京时间12月22日，跌0.26%，卖空量成交38.2万股，较上一交易日减少66.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163559a6c09d0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163559a6c09d0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1191","BK1583","BK1589"],"gpt_icon":0},{"id":"2593512684","title":"翰森制药(03692)制剂孚来美®再获国家基层糖尿病防治管理指南推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2593512684","media":"港美通","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593512684?lang=zh_cn&edition=full","pubTime":"2025-12-22 14:53","pubTimestamp":1766386431,"startTime":"0","endTime":"0","summary":"12月22日，据翰森制药公众号，近日，《中华内科杂志》发布《国家基层糖尿病防治管理指南》，旨在推动基层糖尿病健康管理工作的规范化。翰森制药首个中国原研GLP-1RA周制剂孚来美被纳入指南，这是继2022年版之后再度获得这一国家级重磅指南的认可。翰森制药表示，目前，从权威指南的持续认可，到改变临床实践的心肾肝等获益证据，孚来美正凭借扎实的科研数据，为2型糖尿病治疗提供更全面的选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222150036a4692fe6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222150036a4692fe6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","03692","BK1583","BK1191"],"gpt_icon":0},{"id":"2592954919","title":"每日卖空追踪 | 翰森制药 12月17日卖空量成交87.6万股，卖空比例为15.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592954919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592954919?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960234,"startTime":"0","endTime":"0","summary":"翰森制药北京时间12月17日，跌0.51%，卖空量成交87.6万股，较上一交易日减少66.62%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163537a6ad26b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163537a6ad26b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","03692","BK1583"],"gpt_icon":0},{"id":"2592954803","title":"港股指数小幅高开 恒指涨0.03% 翰森制药(03692)涨1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592954803","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592954803?lang=zh_cn&edition=full","pubTime":"2025-12-17 09:28","pubTimestamp":1765934889,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股指数小幅高开，恒指涨0.03%，国企指数涨0.12%，恒生科技指数涨0.09%。翰森制药涨1.89%，紫金矿业涨1.34%，吉利汽车涨1.13%，龙湖集团涨0.99%。跌幅方面，中国海洋石油跌1.24%，恒安国际跌1.17%，药明康德跌0.99%。锂业股走高，天齐锂业高开3.73%、赣锋锂业高开3.61%，华西证券表示，本周碳酸锂价格环比上涨，碳酸锂持续去库。蓝筹股普遍下跌，投资者年结前保持谨慎，预料指数再度考验25,000点支持，反弹阻力在26,000点水平。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NzMyOTI2MTc2NzYxOTM1NTM3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971682","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422366.SGD","BK4614","LU0871576103.HKD","02833","BK1610","LU0164880469.USD","HEGIY","GELYY","LU0516422440.USD","LU2148510915.USD","LU1064130708.USD","002466","02359","LU0516423174.USD","603259","LU0516422952.EUR","513600","LU0163747925.USD","LU1064131003.USD","LU0149721374.USD","LU0516423091.SGD","01772","LU0979878070.USD","HHImain","LU0164865239.USD","80883","BK1583","BK1528","00960","LGFRY","00883","MCHmain","ZIJMY","09696","002460","LU1242518857.USD","LU0531971595.HKD","LU0039217434.USD","02899","LU0228367735.SGD","LU1242518931.SGD","BK1521","600938","BK1191","601899","03692","01044","BK1589","LU1481107354.HKD","00175","BK1238"],"gpt_icon":0},{"id":"2592491996","title":"翰森制药：葛兰素史克启动B7H4 ADC两项全球三期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2592491996","media":"医药笔记","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592491996?lang=zh_cn&edition=full","pubTime":"2025-12-17 08:22","pubTimestamp":1765930959,"startTime":"0","endTime":"0","summary":"▎Armstrong2025年12月16日，葛兰素史克在Clinicaltrials.gov网站上注册了B7H4 ADC新药GSK5733584治疗子宫内膜癌、卵巢癌的全球三期临床试验，分别计划入组600例、450例受试者。GSK5733584即葛兰素史克从翰森制药引进的HS-20089。翰森制药B7H4 ADC新药HS-20089的通用名为Mocertatug rezetecan。葛兰素史克/翰森制药紧随其后启动卵巢癌、子宫内膜癌两项全球三期临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217085055a6ab741c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217085055a6ab741c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03692","BK1583","BK1589"],"gpt_icon":0},{"id":"2591988727","title":"翰森制药(03692)与GLENMARK就阿美替尼订立许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2591988727","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591988727?lang=zh_cn&edition=full","pubTime":"2025-12-16 18:05","pubTimestamp":1765879533,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药 发布公告，于2025年12月16日，公司全资附属公司江苏豪森药业集团有限公司(许可人)与Glenmark Specialty S.A.就阿美替尼订立独家许可、合作及分销协议。阿美替尼是一款用于治疗非小细胞肺癌的三代表皮生长因子受体-酪氨酸激酶抑制剂。根据许可协议，许可人将授予被许可人独占许可，允许其在授权区域开发并商业化阿美替尼。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1589","BK1191","03692"],"gpt_icon":0},{"id":"2591015695","title":"千亿市值创新药企俱乐部扩容！百济神州、百利天恒、信达生物等强势崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2591015695","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591015695?lang=zh_cn&edition=full","pubTime":"2025-12-15 09:51","pubTimestamp":1765763499,"startTime":"0","endTime":"0","summary":"根据数据统计，截至11月19日，A股和港股的千亿市值创新药企俱乐部已扩容至8家。其中，百济神州A股总市值超过4000亿元，百利天恒总市值超过1500亿元。港股千亿市值俱乐部包括百济神州、翰森制药、信达生物、康方生物等。其中，总市值超4000亿元的创新药企业百济神州已连续两个季度实现盈利。据悉，在研发方面，百济神州的研发管线也进入集中兑现阶段，未来18个月将迎来20项关键里程碑事件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215095603a44bddeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215095603a44bddeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU0588546209.SGD","06160","LU2328871848.SGD","BK1574","BK1589","LU1719994722.HKD","LU2097828631.EUR","LU0307460666.USD","06978","BK1500","02615","HK0000165453.HKD","LU2097828805.USD","LU2488822045.USD","LU1303224171.USD","91194","03692","LU2097828714.EUR","LU1770034418.SGD","LU2097828557.USD","LU2242644610.SGD","BK1161","BK1588","LU1251922891.USD","LU0455707207.USD","LU0502904849.HKD","01801","LU1969619763.USD","LU2097828474.EUR"],"gpt_icon":0},{"id":"2591660538","title":"国产创新药迎利好密集期！九安医疗产品获FDA批准，一品红斩获近70亿元大单","url":"https://stock-news.laohu8.com/highlight/detail?id=2591660538","media":"21世纪经济报道","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591660538?lang=zh_cn&edition=full","pubTime":"2025-12-15 07:27","pubTimestamp":1765754852,"startTime":"0","endTime":"0","summary":"九安医疗公告，公司美国子公司四联检、三联检产品获得美国FDA上市前通知，涉及的产品包括甲型流感、乙型流感、COVID-19及RSV呼吸道合胞病毒四联检测家用试剂盒等。一品红公告，芩香清解口服液获批国家中药二级保护品种。这些优势使中国药企在全球医药交易中的占比迅速提升，2025年成为中国创新药对外授权交易的爆发之年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215073159a44b653b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215073159a44b653b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828474.EUR","LU2097828805.USD","LU2242644610.SGD","01801","LU2328871848.SGD","LU2097828631.EUR","LU0502904849.HKD","LU0455707207.USD","BK1574","LU1969619763.USD","06978","01276","LU2097828714.EUR","LU2097828557.USD","BK1583","03692","BK1589","LU2488822045.USD","BK1161","01877","HK0000165453.HKD"],"gpt_icon":0},{"id":"2590277595","title":"智通港股52周新高、新低统计|12月11日","url":"https://stock-news.laohu8.com/highlight/detail?id=2590277595","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590277595?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:40","pubTimestamp":1765442401,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止12月11日收盘，有28只股票创52周新高，其中亚洲富思、圆美光电、瑞丽医美创高率位于前3位，分别为88.24%、30.43%、22.50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01937","02562","01341","02431","02231","01047","02699","02621","02582","06980","09688","01239","00917","00493","00296","00632","00204","00145","02693","00341","02135","02556","00038","00325","03692","02023","00014","01304","01709","01176","01758","00005","02378","00139","02367","01855","02888","01790","02609","06960","09869","01539","01157","01965","00551","03288","00701","02210","01274"],"gpt_icon":1},{"id":"2590135540","title":"每日卖空追踪 | 翰森制药 12月11日卖空量成交111.8万股，卖空比例为12.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590135540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590135540?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:30","pubTimestamp":1765441833,"startTime":"0","endTime":"0","summary":"翰森制药北京时间12月11日，涨1.98%，卖空量成交111.8万股，较上一交易日减少52.91%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211163602a69915a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211163602a69915a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","03692","BK1589","BK1191"],"gpt_icon":0},{"id":"2590517132","title":"翰森制药12月11日获主力加仓908.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590517132","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590517132?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:16","pubTimestamp":1765440964,"startTime":"0","endTime":"0","summary":"12月11日, 翰森制药股价涨1.98%，报收43.36元，成交金额3.9亿元，换手率0.15%，振幅3.90%，量比0.93。翰森制药今日主力资金净流入908.3万元，连续6日净流入，上一交易日主力净流入327.3万元。近一年数据显示，该股主力连续6日净流入后，次日上涨概率为50.00%，平均涨幅为2.10%。该股近5个交易日上涨7.91%，主力资金累计净流入4419.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.7亿元，其中净流入天数为17日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162308a441f555&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162308a441f555&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","03692","BK1583"],"gpt_icon":0},{"id":"2590605175","title":"中国Biotech“反向授权”时代","url":"https://stock-news.laohu8.com/highlight/detail?id=2590605175","media":"中国医药创新促...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590605175?lang=zh_cn&edition=full","pubTime":"2025-12-11 11:36","pubTimestamp":1765424174,"startTime":"0","endTime":"0","summary":"日本武田制药与信达生物的合作涵盖了三种新型抗癌药物，包括双特异性抗体和ADC技术，这一数字刷新了中国生物科技公司对外授权的记录。这些数据汇集在一起，构成了中国创新药“反向授权”的壮丽图景。如科伦博泰同时与Windward Bio和Crescent Biopharma达成合作，总交易价值超过20亿美元。中国创新药企研发的首个靶向Claudin 18.2的ADC药物已经进入三期临床，这款药物的全球权益以数十亿美元的价格授权给国际药企，标志着一个新时代的开始。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211134144a7315326&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211134144a7315326&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1589","01801","LU2097828474.EUR","LU2097828714.EUR","LU2242644610.SGD","LU2097828805.USD","LU2488822045.USD","LU0455707207.USD","03692","LU0502904849.HKD","LU2097828557.USD","HK0000165453.HKD","LU2097828631.EUR","BK1161","BK1583","LU2328871848.SGD"],"gpt_icon":0},{"id":"2590655105","title":"翰森制药12月10日获主力加仓327.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590655105","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590655105?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:15","pubTimestamp":1765354521,"startTime":"0","endTime":"0","summary":"12月10日, 翰森制药股价涨1.29%，报收42.52元，成交金额3.5亿元，换手率0.14%，振幅3.57%，量比0.90。翰森制药今日主力资金净流入327.3万元，连续5日净流入，上一交易日主力净流入1969.4万元。近一年数据显示，该股主力连续5日净流入后，次日上涨概率为45.45%，平均涨幅为3.15%。该股近5个交易日上涨6.57%，主力资金累计净流入4460.8万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.6亿元，其中净流入天数为17日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210161615a72f42e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210161615a72f42e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1191","BK1583","BK1589"],"gpt_icon":0},{"id":"2590181443","title":"1000亿美元授权交易的背后：中国创新药全球价值突围","url":"https://stock-news.laohu8.com/highlight/detail?id=2590181443","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590181443?lang=zh_cn&edition=full","pubTime":"2025-12-09 11:43","pubTimestamp":1765251807,"startTime":"0","endTime":"0","summary":"恒瑞医药与GSK的120亿美元合作协议落定，当信达生物与武田制药114亿美元的联手刷屏行业，2025年中国创新药对外授权交易迎来爆发。有数据显示，仅2025年前三季度，中国创新药对外授权总金额已突破1000亿美元。而授权交易数据的爆发式增长，直观展现了全球市场对中国创新价值的认可。业内表示，中国创新药的价值跃升，本质是研发实力与成本优势的双重赋能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209114610a72c6f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209114610a72c6f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","LU2328871848.SGD","01276","BK1589","LU2097828631.EUR","HK0000165453.HKD","BK1574","LU2097828557.USD","LU2242644610.SGD","03692","LU2097828714.EUR","LU1969619763.USD","01801","09995","BK1583","06978","01530","LU2097828805.USD","LU0455707207.USD","LU0502904849.HKD","LU2097828474.EUR"],"gpt_icon":0},{"id":"2590318118","title":"医药生物行业动态报告：医药行业周度复盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2590318118","media":"中信建投证券股...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590318118?lang=zh_cn&edition=full","pubTime":"2025-12-09 11:33","pubTimestamp":1765251229,"startTime":"0","endTime":"0","summary":"2）生物制品：板块本周跑输医药指数及大盘。板块跟随医药行业整体回调，部分个股本周受股权变更落地等因素影响，股价有所提升。3）医药商业：本周跑赢申万医药及大盘。25Q3公募基金医药持仓：环比持续提升，创新药、CXO行业有所加配。本周恒生医疗保健下跌0.71%，恒生指数上涨0.87%，恒生医疗保健整体跑输大盘1.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209113352a72c6979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209113352a72c6979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","01276","09926","BK1574","09939","BK1515","BK1161"],"gpt_icon":0},{"id":"2590939552","title":"每日卖空追踪 | 翰森制药 12月08日卖空量成交112.4万股，卖空比例为12.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590939552","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590939552?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182633,"startTime":"0","endTime":"0","summary":"翰森制药北京时间12月08日，涨0.29%，卖空量成交112.4万股，较上一交易日减少86.45%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816353695310a2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816353695310a2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","03692","BK1589","BK1191"],"gpt_icon":0},{"id":"2590739550","title":"翰森制药12月08日获主力加仓563.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590739550","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590739550?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181745,"startTime":"0","endTime":"0","summary":"12月08日, 翰森制药股价涨0.29%，报收42.06元，成交金额3.8亿元，换手率0.15%，振幅2.96%，量比1.10。翰森制药今日主力资金净流入563.5万元，连续3日净流入，上一交易日主力净流入651.2万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为60.00%，平均涨幅为2.62%。该股近5个交易日上涨4.59%，主力资金累计净流入3050.5万元；近20日主力资金累计净流入1.4亿元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208161929a43af0e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208161929a43af0e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03692","BK1583","BK1589"],"gpt_icon":0},{"id":"2589356587","title":"跨国巨头抄底中国创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2589356587","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589356587?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:14","pubTimestamp":1765181695,"startTime":"0","endTime":"0","summary":"产业领域的跨国公司在行业最为低迷之际仍在进行抄底操作，这是因为其洞察到中国创新药产业在底层的创新能力、研发能力以及临床能力均在持续提升，这便是今年上半年众多跨国公司纷纷展开大规模收购行动的缘由。数据显示，2025年前三季度，中国创新药板块上市公司整体实现营业收入488.3亿元，同比增长22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208162028a72aa660&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208162028a72aa660&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU1969619763.USD","BK1583","01276","09995","06978","BK1574","01801","03692","LU2328871848.SGD"],"gpt_icon":0},{"id":"2589804543","title":"智通港股沽空统计|12月8日","url":"https://stock-news.laohu8.com/highlight/detail?id=2589804543","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589804543?lang=zh_cn&edition=full","pubTime":"2025-12-08 08:20","pubTimestamp":1765153226,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，新鸿基地产-R、华润啤酒-R、友邦保险-R上一交易日沽空比率位于前三位，分别为100.00%、100.00%、100.00%。小米集团-W、中国平安、阿里巴巴-SW的沽空金额位居前三，分别为21.96 亿元、19.56 亿元、11.60 亿元。中银香港-R、中国移动-R、大家乐集团的偏离值位居前三，分别为52.21%、41.86%、40.03%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MIUmain","002594","HMTD.SI","03968","02318","09988","81299","82331","80941","00939","BYDDY","03145","82388","03692","03143","00136","89888","81211","PNGAY","601318","82318","BABA","METmain","LU1224709979.USD","80700","00916","TCHmain","LU0871576103.HKD","80291","HYDD.SI","XIACY","HPAD.SI","ALBmain","LU0949170772.SGD","81810","02899","HXXD.SI","80016","LU0143863784.USD","01579","00341","PAImain","01801","01810","LU0683595622.HKD"],"gpt_icon":1},{"id":"2589809298","title":"翰森制药(03692)：创新药阿美乐®新增两项适应症成功纳入新版2025国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589809298","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589809298?lang=zh_cn&edition=full","pubTime":"2025-12-08 07:05","pubTimestamp":1765148745,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药 发布公告，本集团创新药阿美乐新增两项适应症成功纳入新版《国家基本医疗保险、工伤保险和生育保险药品目录》，圣罗莱、恒沐所有适应症续约纳入2025国家医保目录，新版国家目录将于2026年1月1日正式实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","BK1589","06978","BK1574","BK1161","BK1191","BK1583","03692"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0373},{"period":"1month","weight":-0.0131},{"period":"3month","weight":0.0784},{"period":"6month","weight":0.3093},{"period":"1year","weight":1.1381},{"period":"ytd","weight":1.2049}],"compareEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.022},{"period":"3month","weight":-0.0281},{"period":"6month","weight":0.0596},{"period":"1year","weight":0.2963},{"period":"ytd","weight":0.2849}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。该公司的创新药产品包括阿美乐、豪森昕福、迈灵达、孚来美、恒沐、昕越、圣罗莱等产品。该公司的创新药产品主要应用于抗肿瘤、抗感染、中枢神经系统（CNS）疾病、代谢及其他治疗领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.014633},{"month":2,"riseRate":0.5,"avgChangeRate":0.00076},{"month":3,"riseRate":0.333333,"avgChangeRate":0.024785},{"month":4,"riseRate":0.5,"avgChangeRate":0.03201},{"month":5,"riseRate":0.666667,"avgChangeRate":0.019349},{"month":6,"riseRate":0.666667,"avgChangeRate":0.055622},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.000332},{"month":8,"riseRate":0.714286,"avgChangeRate":0.01897},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.033021},{"month":10,"riseRate":0.142857,"avgChangeRate":0.001586},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063467},{"month":12,"riseRate":0.571429,"avgChangeRate":0.022541}],"exchange":"SEHK","name":"翰森制药","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰森制药,03692,翰森制药股票,翰森制药股票老虎,翰森制药股票老虎国际,翰森制药行情,翰森制药股票行情,翰森制药股价,翰森制药股市,翰森制药股票价格,翰森制药股票交易,翰森制药股票购买,翰森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}